21st Drug Discovery & Development Nexus 2024 New York

About Us

Welcome to the 21st BioPharma Drug Discovery Nexus Conference, happening on 22nd-23rd October in the charming city of New Jersey. This conference provides a unique opportunity for service providers focused on business development to connect with industry leaders and explore potential collaborations. The event offers a dynamic platform for networking and engagement, allowing participants to forge meaningful connections, discover new business prospects, and stay at the forefront of the evolving landscape in drug discovery. Join us for this business-centric experience as we facilitate connections and opportunities that drive success in the pharmaceutical and biotech sectors.

Our Worldwide Audience

Sector

Region

Job Function

Our Invited Speakers

Fernando Aleman

Co-founder and CSO

Navega Therapeutics, Inc.

Brian Slattery

Director CMC Project Management

Reata Pharmaceuticals, Inc.

Minghao Sun

Vice President, Head of Research & Product Development

Capricor Therapeutics, Inc

Mauro Mileni

Fouder and CEO

Abilita Therapeutics

Jian Chen

Director, Translational Research and Preclinical Development

BioAtla, Inc.

Vince Yeh, Ph.D

Director of Medicinal Chemistry

Trotana Therapeutics

Thomas Dailey

Senior Manager, In Vivo Pharmacology

Fate Therapeutics

Nicholas Wisniewski

Vice President of Bioinformatics and Data Science

Stemson Therapeutics

Andrew Zhang

Director, Chemical Biology

AstraZeneca

Shipra Malhotra

Senior Scientist, Biologics, Computational Biology / Machine Learning

Takeda

Agenda Streams

Automation & Computational Drug Design

Antibody Therapeutics & Protein Engineering

Novel Targets: Exploring Modalities in Drug Discovery

Advancement in Cell & Gene Therapy

Benefits Of Attending The Conference

Building Meaningful Relations

Stay Current with Trends by Learning from Powerful Speakers

Connect with Influencers & in Turn, Your Target Audience

Get Fresh Ideas and Solutions for Your Business

Testimonials

This conference was very important for us because of the topics that were chosen for presentations and there were also qualified meetings and the meeting that we had was very relevant.

SATISH NAGRAJ

Associate Vice President

JUBILANT BIOSYS

The meeting here presented new technologies, new ways of drug discoveries, new ways of thinking of how to discover drugs and I gained a lot out of it. I hope that I will be able to follow up with that in the future.

MARK FEITELSON

CSO

SFA THERAPEUTICS

This has been a very rich, diverse and inspiring conference and networking opportunities were excellence. I can recommend the conference and wish the producers good luck in future.

TORSTEN HOFFMANN

CSO

SILENCE THERAPEUTICS

I would like to say that it was a very interesting, very good meeting with very different types of presentations coming from different angles bringing people together, very good discussions.

Geert Mudde

CSO & Founder

OncoQR ML

First time coming to this conference the organizers did a great job setting up one to one meetings with us and the company presentations the topics were relevant and look forward to coming back again next year

Jeff Goddard

VP, BD

AIT Bioscience

It was a program that had a great deal of scientific interest and leading edge technologies. I was a very impressive group of presenters and I was very happy that I was invited to present and it was a privilege to be so.

Don Van Dyke

COO

Cloud Pharmaceuticals

This is a very interesting and productive conference. I have learned a lot during these two days and met a lot of interesting people.I look forward to seeing the agenda of the next conference.